Kantonsspital St.Gallen
login

Celgene CC-10004

Andrea Rubbert Roth, Silvia Forrer, Mira Bartz Batliner & Thomas Neumann

abstract A PHASE 4, MULTICENTER, SINGLE-ARM, OPENLABEL
STUDY TO EVALUATE THE IMPACT OF
APREMILAST (CC-10004) ON MRI OUTCOMES IN
SUBJECTS WITH PSORIATIC ARTHRITIS
   
type of project clinical studies
status ongoing - recruiting phase
start of project 2019
end of project 2021
study design This is a Phase 4, multicenter, single-arm, open-label study to evaluate the impact of apremilast,
either in monotherapy or with stable MTX, on MRI outcomes in subjects with active PsA with
up to 5 years of disease duration (since diagnosis).
responsible person Andrea Rubber-Roth